Author:
Yu Wenhao,Zhang Qi,Ali Muhammad,Chen Bangquan,Yang Yapeng,Wang Liuhua,Sun Qiannan,Wang Yong,Wang Daorong
Abstract
Abstract
Background
This study aimed to create a nomogram for predicting the recurrence of small bowel obstruction (SBO) after gastrectomy in patients with gastric cancer (GC) in order to provide better guidance for its diagnosis and treatment.
Methods
A total of 173 patients undergone gastrectomy and developed SBO from January 2015 to October 2022 were admitted into this case–control study. The risk factors of postoperative recurrent SBO were analyzed by univariate and multivariate regression, and a nomogram for predicting the recurrent SBO after gastrectomy was developed using R Studio.
Results
Thirty-nine cases of postoperative recurrent SBO occurred among the 173 GC patients who underwent radical gastrectomy, and the percentage of recurrent SBO was 22.54% (39/173). Age [odds ratio (OR) = 0.938, p = 0.026], WBC count (OR = 1.547, p < 0.001), tumor size (OR = 1.383, p = 0.024), postoperative metastasis (OR = 11.792, p = 0.030), and the interval from gastrectomy to first SBO (OR = 1.057, p < 0.001) were all identified as independent risk factors for postoperative recurrent SBO by logistic regression analysis. The receiver operating characteristic curve, the calibration curve, the model consistency index, and the decision curve analysis showed that the nomogram had good predictive performance.
Conclusion
Based on these factors, we created a nomogram to predict the occurrence of postoperative recurrent SBO. This novel nomogram could serve as a crucial early warning indicator that would guide doctors to make informed decisions while managing patients with gastric cancer.
Funder
the National Natural Science Foundation of China
Key Laboratory of Basic and Clinical Transformation of Digestive and Metabolic Diseases, Yangzhou, China
the Natural Science Foundation of Jiangsu Province
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. https://doi.org/10.3322/caac.21492.
2. Zamary K, Spain DA. Small bowel obstruction: the sun also rises? J Gastrointest Surg. 2020;24:1922–8. https://doi.org/10.1007/s11605-019-04351-5.
3. Ellis H, Moran BJ, Thompson JN, Parker MC, Wilson MS, Menzies D, McGuire A, Lower AM, Hawthorn RJ, O’Brien F, Buchan S, Crowe AM. Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet. 1999;353:1476–80. https://doi.org/10.1016/S0140-6736(98)09337-4.
4. Foster NM, McGory ML, Zingmond DS, Ko CY. Small bowel obstruction: a population-based appraisal. J Am Coll Surg. 2006;203:170–6. https://doi.org/10.1016/j.jamcollsurg.2006.04.020.
5. Korenaga D, Yasuda M, Takesue F, Honda M, Inutsuka S, Nagahama S, Maekawa S. Factors influencing the development of small intestinal obstruction following total gastrectomy for gastric cancer: the impact of reconstructive route in the Roux-en-Y procedure. Hepatogastroenterology. 2001;48:1389–92.